ZOETIS INC COM USD0.01 CL 'A'

Symbol: ZTS

This security went ex-dividend on 18/07/2024. Pay date is 04/09/2024

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date Unknown
Pay Date Unknown
Total Dividends - Year to Date0
Dividend Yield (%)0

Historical Data & Ratios

Avg Volume Over 10 Days2.0413
Market Cap (M)81695.0800
Price/Earnings (PE)0
Earnings Per Share0
Revenue Per Share0
Return on Equity %0

1 Month Performance Chart

One Month Chart

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.35% per annum for Funds (up to £250,000) and Stocks & Shares (min £24 max £240), plus SIPP administration fee (if applicable, only charged if <£30,000 held) - see here
0.35%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that no government taxes, levies or financial transaction taxes are included. International equities incur additional costs including an International dealing rate that will be shown at the point of trade, as well as possible exchange costs when trading in overseas markets
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. It has a diversified business, commercializing products across eight core species: dogs, cats and horses (companion animals) and cattle, swine, poultry, fish and sheep (livestock); and within seven major product categories: parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics and medicated feed additives. The Company operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.

      Financial Summary

      BRIEF: For the three months ended 31 March 2024, Zoetis Inc revenues increased 10% to $2.19B. Net income increased 9% to $599M. Revenues reflect US segment increase of 16% to $1.16B, International segment increase of 3% to $1.01B, United States segment increase of 16% to $1.16B, Brazil segment increase of 20% to $101M. Net income was partially offset by Selling, General and Administrative Exp increase of 8% to $547M (expense).

      Financials


      Income Statement - All values are in U.S. Dollars

      Year Ending

      31/12/2023

      31/12/2022

      31/12/2021

      31/12/2020

      31/12/2019

      31/12/2018

      Total Revenue 8,544.00 8,080.00 7,776.00 6,675.00 6,260.00 5,825.00
      Gross profit 6,020.00 5,630.00 5,483.00 4,630.00 4,284.00 3,942.00
      Operating Profit/Loss 2,936.00 2,656.00 2,488.00 1,996.00 1,801.00 1,690.00
      Profit Before Tax 2,936.00 2,656.00 2,488.00 1,996.00 1,801.00 1,690.00
      Profit After Tax 2,340.00 2,111.00 2,034.00 1,636.00 1,500.00 1,379.00
      Equity Holders of Parent Company 2,344.00 2,114.00 2,037.00 1,638.00 1,500.00 1,428.00
      Minority Interest -2.00 1.00 4.00 6.00 NIL 4.00


      Balance Sheet - All values are in U.S. Dollars

      Year Ending

      31/12/2023

      31/12/2022

      31/12/2021

      31/12/2020

      31/12/2019

      31/12/2018

      Total Non-Current Assets 7,943.00 7,419.00 6,970.00 6,998.00 6,797.00 6,378.00
      Total Current Assets 6,343.00 7,506.00 6,930.00 6,611.00 4,748.00 4,399.00
      Total Assets 14,286.00 14,925.00 13,900.00 13,609.00 11,545.00 10,777.00
      Total Liabilities 9,295.00 10,522.00 9,356.00 9,836.00 8,837.00 8,592.00
      Total Net Assets 4,991.00 4,403.00 4,544.00 3,773.00 2,708.00 2,185.00
      Shareholders Funds 4,997.00 4,405.00 4,543.00 3,769.00 2,708.00 2,185.00
      Minority Interests -2.00 1.00 4.00 6.00 NIL 4.00
      Total Equity 4,991.00 4,403.00 4,544.00 3,773.00 2,708.00 2,185.00

      Outlook

      Sorry, broker view information on this investment is not available at this time.

      Time & Sales

      Sorry, sales information on this investment is not available at this time.

      Investment involves risk. You may get back less than invested.